Short Interest in Gyrodyne , LLC (NASDAQ:GYRO) Expands By 25.8%

Gyrodyne , LLC (NASDAQ:GYROGet Free Report) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 989 shares, an increase of 25.8% from the March 31st total of 786 shares. Based on an average daily volume of 1,153 shares, the short-interest ratio is currently 0.9 days. Currently, 0.1% of the shares of the stock are sold short.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Advisory Services Network LLC acquired a new position in shares of Gyrodyne during the 3rd quarter worth about $77,000. Susquehanna International Group LLP acquired a new stake in Gyrodyne in the 3rd quarter valued at about $142,000. Teton Advisors LLC acquired a new stake in Gyrodyne in the 3rd quarter valued at about $177,000. Finally, Bulldog Investors LLP acquired a new stake in Gyrodyne in the 3rd quarter valued at about $601,000. Institutional investors and hedge funds own 71.36% of the company’s stock.

Gyrodyne Stock Down 1.0%

Shares of GYRO traded down $0.07 during mid-day trading on Friday, hitting $7.53. 705 shares of the company were exchanged, compared to its average volume of 1,057. Gyrodyne has a 1-year low of $6.70 and a 1-year high of $12.00. The company has a 50 day moving average of $8.11 and a 200-day moving average of $8.92.

About Gyrodyne

(Get Free Report)

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.

Further Reading

Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.